Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
University of California San Francisco
Give to UCSFA common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
UCSF primary care physician and researcher Alka M. Kanaya, MD, is being recognized with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).
A new study shows that newborn screening for SCID is the only factor that actually boosts survival rates.
After diagnosing a middle-aged man with an incredibly rare and almost always fatal infection, a medical team led by UCSF fellow Natasha Spottiswoode raced to find a treatment that could save his life.
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
In a breakthrough, “HT” became the first person in the world to receive gene-corrected stem cells for Artemis-SCID.
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response.
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
While some patients recover from the effects of COVID-19, others experience the aftereffects long after the initial infection. UC San Francisco researchers are studying why some COVID-19 patients
UCSF faculty members Walter G. Gonzalez and Angela Phillips have been selected as Howard Hughes Medical Institute (HHMI) Freeman Hrabowski Scholars. With up to $8.6 million in support, they will conduct research, create inclusive lab environments, and make a significant impact on the future of science. Both scholars are committed to fostering diversity and promoting scientific breakthroughs.
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.
Immunologist and UCSF Professor Emeritus Jeffrey Bluestone, PhD, has been elected to the National Academy of Sciences (NAS) – one of the highest honors bestowed on American scientists.
Avian flu cases are spiking. Will it spill over into humans?
Oakland residents have bought fewer sugary beverages since a local “soda tax” went into effect, and that is likely improving their health and saving the city money.
Ten graduate school finalists competed in this year’s UCSF Grad Slam, in which students present their research in three minutes or less in terms easily understood by a general audience.